Lee Sean Qiu En, Tan Tsu Soo, Kawamukai Makoto, Chen Ee Sin
Department of Biochemistry, National University of Singapore, Singapore, Singapore.
School of Chemical & Life Sciences, Nanyang Polytechnic, Singapore, Singapore.
Microb Cell Fact. 2017 Mar 2;16(1):39. doi: 10.1186/s12934-017-0646-4.
Coenzyme Q (CoQ), a benzoquinone present in most organisms, plays an important role in the electron-transport chain, and its deficiency is associated with various neuropathies and muscular disorders. CoQ is the only lipid-soluble antioxidant found in humans, and for this, it is gaining popularity in the cosmetic and healthcare industries. To meet the growing demand for CoQ, there has been considerable interest in ways to enhance its production, the most effective of which remains microbial fermentation. Previous attempts to increase CoQ production to an industrial scale have thus far conformed to the strategies used in typical metabolic engineering endeavors. However, the emergence of new tools in the expanding field of synthetic biology has provided a suite of possibilities that extend beyond the traditional modes of metabolic engineering. In this review, we cover the various strategies currently undertaken to upscale CoQ production, and discuss some of the potential novel areas for future research.
辅酶Q(CoQ)是一种存在于大多数生物体中的苯醌,在电子传递链中起着重要作用,其缺乏与各种神经病变和肌肉疾病有关。CoQ是人类发现的唯一一种脂溶性抗氧化剂,因此,它在化妆品和医疗保健行业越来越受欢迎。为了满足对CoQ不断增长的需求,人们对提高其产量的方法产生了浓厚兴趣,其中最有效的方法仍然是微生物发酵。此前将CoQ产量提高到工业规模的尝试迄今为止都遵循了典型代谢工程努力中使用的策略。然而,合成生物学不断扩展的领域中出现的新工具提供了一系列超越传统代谢工程模式的可能性。在这篇综述中,我们涵盖了目前为扩大CoQ产量而采取的各种策略,并讨论了一些未来研究的潜在新领域。